REGULATED PRESS RELEASE published on 04/22/2025 at 07:01, 9 months 13 days ago WATCHFIRE™ by bioMérieux: a PCR test to detect viruses and bacteria in wastewater and respond to potential infectious disease outbreaks bioMérieux launches WATCHFIRE™, a PCR test detecting viruses and bacteria in wastewater to monitor infectious disease outbreaks. Revolutionary solution for public health BioMérieux PCR Test WATCHFIRE™ Wastewater Infectious Disease Outbreaks
REGULATED PRESS RELEASE published on 04/22/2025 at 07:01, 9 months 13 days ago WATCHFIRE™, un nouveau test PCR développé par bioMérieux pour détecter les virus et les bactéries dans les eaux usées et affronter d’éventuelles épidémies de maladies infectieuses bioMérieux lance WATCHFIRE™, un test PCR innovant pour détecter virus et bactéries dans les eaux usées, renforçant la surveillance de la santé publique BioMérieux Santé Publique Test PCR Eaux Usées WATCHFIRE™
BRIEF published on 04/17/2025 at 07:06, 9 months 18 days ago Performance Financière de bioMérieux au Premier Trimestre 2025 Résultats Financiers Croissance BioMérieux BIOFIRE SPOTFIRE
BRIEF published on 04/17/2025 at 07:06, 9 months 18 days ago BioMérieux Reports Strong First-Quarter 2025 Growth BioMérieux GO•28 Strategic Plan Q1 2025 Growth SPOTFIRE® Sales CEBIT Projections
REGULATED PRESS RELEASE published on 04/17/2025 at 07:01, 9 months 18 days ago bioMérieux – Information financière du 1er trimestre 2025 bioMérieux annonce une croissance organique de +12,7% au premier trimestre 2025, confirmant ses objectifs de croissance des ventes et du résultat opérationnel pour l'année Croissance BioMérieux Résultat Opérationnel Ventes Objectifs
REGULATED PRESS RELEASE published on 04/17/2025 at 07:01, 9 months 18 days ago bioMérieux – First-Quarter 2025 Business Review bioMérieux reports strong Q1 2025 results with +12.7% organic sales growth, reiterates sales guidance of +7% with steady CEBIT growth. Acquisition of Neoprospecta and SpinChip boosts Point of Care presence Acquisition BioMérieux Organic Sales Growth Q1 2025 CEBIT Growth
BRIEF published on 04/07/2025 at 07:06, 9 months 28 days ago BioMérieux obtient le marquage CE pour LUMED™ APSS™ BioMérieux Antibiorésistance Santé Publique Antibiotiques Aide À La Décision
BRIEF published on 04/07/2025 at 07:06, 9 months 28 days ago BioMérieux Achieves CE Marking for LUMED™ APSS™ to Enhance Antimicrobial Stewardship BioMérieux Healthcare Antimicrobial Stewardship CE Marking LUMED APSS
REGULATED PRESS RELEASE published on 04/07/2025 at 07:01, 9 months 28 days ago bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship. LUMED™ APSS™ enhances antimicrobial stewardship programs by offering real-time alerts, data-driven decisions, and tailored support for medical teams BioMérieux Clinical Decision Support System Antimicrobial Stewardship CE-marking LUMED APSS
REGULATED PRESS RELEASE published on 04/07/2025 at 07:01, 9 months 28 days ago bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle de pointe pour aider à prendre des décisions en matière de bon usage des antibiotiques bioMérieux obtient le marquage CE pour LUMED™ APSS™, une solution logicielle avancée pour le bon usage des antibiotiques. Lancement européen imminent BioMérieux Marquage CE Santé LUMED APSS Bon Usage Antibiotiques
Published on 02/05/2026 at 09:05, 20 minutes ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 7 hours 50 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 9 hours 25 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/05/2026 at 09:00, 25 minutes ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 25 minutes ago Original-Research: Limes Schlosskliniken AG (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 25 minutes ago Original-Research: Semperit AG Holding (von NuWays AG): BUY
Published on 02/05/2026 at 09:00, 25 minutes ago Novem Group S.A.: Q3 2025/26 shows steady Series sales
Published on 02/04/2026 at 18:04, 15 hours 21 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 15 hours 21 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 15 hours 40 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 15 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL